Pharmacology of absence epilepsy

1989, Proposal for revised classification of epilepsies and epileptic syndromes Commission on Classification and Terminology of the International League Against Epilepsy, Epilepsia, 30, 389, 10.1111/j.1528-1157.1989.tb05316.x

Crunelli, 2002, Childhood absence epilepsy: genes, channels, neurons and networks, Nat. Rev. Neurosci., 3, 371, 10.1038/nrn811

Gibbs, 1935, The EEG in epilepsy and in conditions of impaired consciousness, Arch. Neurol., 34, 1134, 10.1001/archneurpsyc.1935.02250240002001

Snead, 1995, Basic mechanisms of generalised absence seizures, Ann. Neurol., 37, 146, 10.1002/ana.410370204

Sarkisian, 2001, Overview of the current animal models for human seizure and epileptic disorders, Epilepsy Behav., 2, 201, 10.1006/ebeh.2001.0193

Felix, 2002, Insights from mouse models of absence epilepsy into Ca2+ channel physiology and disease etiology, Cell. Mol. Neurobiol., 22, 103, 10.1023/A:1019807719343

Danober, 1998, Pathophysiological mechanisms of genetic absence epilepsy in the rat, Prog. Neurobiol., 55, 27, 10.1016/S0301-0082(97)00091-9

Coenen, 1992, Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats, Epilepsy Res., 12, 75, 10.1016/0920-1211(92)90029-S

Cortez, 2001, A model of atypical absence seizures: EEG, pharmacology, and developmental characterization, Neurology, 56, 341, 10.1212/WNL.56.3.341

Avoli, 1982, Interaction of the cortex and thalamus in spike wave discharges of feline generalised penicillin epilepsy, Exp. Neurol., 76, 196, 10.1016/0014-4886(82)90112-1

Gloor, 1988, Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy, Trends Neurosci., 11, 63, 10.1016/0166-2236(88)90166-X

Penfield, 1947, Highest level seizures, Assoc. Nerv. Ment. Dis. Proc., 26, 252

Vergnes, 1987, Spontaneous spike and wave discharges in thalamus and cortex in a rat model of genetic petit mal-like seizures, Exp. Neurol., 96, 127, 10.1016/0014-4886(87)90174-9

Blumenfeld, 2000, Corticothalamic inputs control the pattern of activity generated in thalamocortical networks, J. Neurosci., 20, 5153, 10.1523/JNEUROSCI.20-13-05153.2000

Avanzini, 1992, Role of the thalamic reticular nucleus in the generation of rhythmic thalamo-cortical activities subserving spikes and waves, J. Neural Transm., 35, 85

Vergnes, 1984, Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy, Neurosci. Lett., 44, 91, 10.1016/0304-3940(84)90226-X

Mirsky, 1986, Petit mal epilepsy: a review and integration of recent information, J. Clin. Neurophysiol., 3, 179, 10.1097/00004691-198607000-00001

Liu, 1991, Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat, Brain Res., 545, 1, 10.1016/0006-8993(91)91262-Y

Liu, 1992, Involvement of intrathalamic GABAB neurotransmission in the control of absence seizures in the rat, Neuroscience, 48, 87, 10.1016/0306-4522(92)90340-8

Richards, 2003, Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy, Epilepsy Res., 54, 97, 10.1016/S0920-1211(03)00060-3

D'Arcangelo, 2002, Thalamocortical oscillations in a genetic model of absence seizures, Eur. J. Neurosci., 16, 2383, 10.1046/j.1460-9568.2002.02411.x

Seidenbecher, 1998, Relations between cortical and thalamic cellular activities during absence seizures in rats, Eur. J. Neurosci., 10, 1103, 10.1046/j.1460-9568.1998.00123.x

Steriade, 1998, Spike-wave complexes and fast components of cortically generated seizures. I. Role of neocortex and thalamus, J. Neurophysiol., 80, 1439, 10.1152/jn.1998.80.3.1439

Meeren, 2002, Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats, J. Neurosci., 22, 1480, 10.1523/JNEUROSCI.22-04-01480.2002

Loscher, 1999, Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action, Prog. Neurobiol., 58, 31, 10.1016/S0301-0082(98)00075-6

Loscher, 1989, Valproate enhances GABA turnover in the substantia nigra, Brain Res., 501, 198, 10.1016/0006-8993(89)91044-5

Johannessen, 2000, Mechanisms of action of valproate: a commentatory, Neurochem. Int., 37, 103, 10.1016/S0197-0186(00)00013-9

Johannessen, 2003, Valproate: past, present, and future, CNS Drug Rev., 9, 199, 10.1111/j.1527-3458.2003.tb00249.x

McLean, 1986, Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell-culture, J. Pharmacol. Exp. Ther., 237, 1001

Zona, 1990, Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell-culture, Exp. Brain Res., 81, 313, 10.1007/BF00228121

Vreugdenhil, 1999, Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis, Epilepsia, 40, 1512, 10.1111/j.1528-1157.1999.tb02034.x

Slevin, 1985, Chronic valproic acid therapy and synaptic markers of amino acid neurotransmission, Neurology, 35, 728, 10.1212/WNL.35.5.728

Dixon, 1997, The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-triphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates, Proc. Natl. Acad. Sci. U. S. A., 94, 4757, 10.1073/pnas.94.9.4757

Coulter, 1989, Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons, Ann. Neurol., 25, 582, 10.1002/ana.410250610

Gomora, 2001, Block of cloned human T-type calcium channels by succinimide antiepileptic drugs, Mol. Pharmacol., 60, 1121, 10.1124/mol.60.5.1121

Lacinova, 2000, Regulation of the calcium channel alpha(1G) subunit by divalent cations and organic blockers, Neuropharmacology, 39, 1254, 10.1016/S0028-3908(99)00202-6

Kim, 2001, Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha1G T-type Ca2+ channels, Neuron, 31, 35, 10.1016/S0896-6273(01)00343-9

Coulter, 1989, Specific petit mal anticonvulsants reduce calcium currents in thalamic neurons, Neurosci. Lett., 98, 74, 10.1016/0304-3940(89)90376-5

Leresche, 1998, On the action of the anti-absence drug ethosuximide in the rat and cat thalamus, J. Neurosci., 18, 4842, 10.1523/JNEUROSCI.18-13-04842.1998

Manning, 2003, Ethosuximide has a powerful anti-absence action when bilaterally infused directly into the somatosensory cortex (S1) of the genetic absence epilepsy rat from Strasbourg (GAERS), Br. J. Pharmacol., 138, 2P

Rogawski, 1990, Antiepileptic drugs – pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmacol. Rev., 42, 223

Van Luijtelaar, 1995, Effects of remacimide and its metabolite FPL 12495 on spike-wave discharges, electroencephalogram and behaviour in rats with absence epilepsy, Neuropharmacology, 34, 419, 10.1016/0028-3908(95)00008-T

Nehlig, 2003, Effects of remacemide in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS, Epilepsy Res., 52, 253, 10.1016/S0920-1211(02)00236-X

Dufour, 2001, Metabolic approach of absence seizures in a genetic model of absence epilepsy, the GAERS: study of the leucine–glutamate cycle, J. Neurosci. Res., 66, 923, 10.1002/jnr.10086

Coulter, 1997, Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in?, J. Child Neurol., 12, S2, 10.1177/0883073897012001031

Zona, 2001, Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents, Seizure, 10, 279, 10.1053/seiz.2000.0504

Lukyanetz, 2002, Selective blockade of N-type calcium channels by levetiracetam, Epilepsia, 43, 9, 10.1046/j.1528-1157.2002.24501.x

Loscher, 1996, The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulate, Brain Res., 735, 208, 10.1016/0006-8993(96)00587-2

Marescaux, 1992, GABAB receptor antagonists: potential new anti-absence drugs, J. Neural Transm. Suppl., 35, 179

Hosford, 1995, Characterization of the antiabsence effects of SCH 50911, a GABAB antagonist, in the lethargic mouse, γ-hydroxybutyrate, and pentylenetetrazole models, J. Pharmacol. Exp. Ther., 274, 1399

Crunelli, 1991, A role for GABAB receptors in excitation and inhibition of thalamocortical cells, Trends Neurosci., 14, 16, 10.1016/0166-2236(91)90178-W

Kochen, 2002, Spike-and-wave complexes and seizure exacerbation caused by carbamazepine, Eur. J. Neurol., 9, 41, 10.1046/j.1468-1331.2002.00317.x

Li, 2002, Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?, J. Affect. Disord., 69, 1, 10.1016/S0165-0327(00)00361-X

Williams, 2002, A common mechanism of action for three mood-stabilizing drugs, Nature, 417, 292, 10.1038/417292a

Genton, 2000, When anti-epileptic drugs aggravate epilepsy, Brain Dev., 22, 75, 10.1016/S0387-7604(99)00113-8

Trudeau, 1996, Gabapentin in naı̈ve childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies, J. Child Neurol., 11, 470, 10.1177/088307389601100611

Vossler, 1996, Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin, Neurology, 46, 852

Bowery, 2002, International Union of Pharmacology. XXXIII. Mammalian γ-aminobutyric acidB receptors: structure and function, Pharmacol. Rev., 54, 247, 10.1124/pr.54.2.247

Taylor, 1998, A summary of mechanistic hypotheses of gabapentin pharmacology, Epilepsy Res., 29, 233, 10.1016/S0920-1211(97)00084-3

Panayiotopoulos, 2001, Treatment of typical absence seizures and related epileptic syndromes, Paediatr. Drugs, 3, 379, 10.2165/00128072-200103050-00006

Llinas, 1999, Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography, Proc. Natl. Acad. Sci. U. S. A., 96, 15222, 10.1073/pnas.96.26.15222

Ritchie, 2003, Treatment of spontaneous and chemically induced EEG paroxysms in the Fischer-344 rat with traditional antiepileptic drugs or AED+CGP 35348 polytherapy, Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 847, 10.1016/S0278-5846(03)00144-1

Panayiotopoulos, 2002